ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases

Completed
Institution
INTRAVACC B.V.
Principal investigator
Corine Kruiswijk
Funding
$1.2M
Duration
2022–2026

Moonbase score

Still being scored

Abstract

To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases, including emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESN01infectiousvaccineinfectious diseasesvaccine candidatesemerging infectiousind enablingantibiotic-resistantind

Questions for Intravacc B.V.

Intravacc B.V. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.

Same institution, same topic, scored first.